The efficacy and safety of 2.5% testosterone gel for late-onset hypogonadsism patients evaluated by using salivary testosterone.

Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2008
This article has no abstract
Epistemonikos ID: bf80b3447e5cf21bea32a420d3afe471e8b2a99f
First added on: Apr 16, 2025